Beneficial effect of ovocystatin on the cognitive decline in APP/PS1 transgenic mice

Mayeux, 2012, Epidemiology of Alzheimer disease, Cold Spring Harb Perspect Med, 2, 1, 10.1101/cshperspect.a006239 Guerreiro, 2015, The age factor in Alzheimer’s disease, Genome Med, 7, 106, 10.1186/s13073-015-0232-5 Lobo, 2000, Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts, Neurology, 54, S4 Selkoe, 2001, Alzheimer’s disease: genes, proteins, and therapy, Physiol Rev, 81, 741, 10.1152/physrev.2001.81.2.741 Finckh, 2005, Novel mutations and repeated findings of mutations in familial Alzheimer disease, Neurogenetics, 6, 85, 10.1007/s10048-005-0211-x Jarrett, 1993, The carboxy terminus of the amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of alzheimer’s disease, Biochemistry, 32, 4693, 10.1021/bi00069a001 Eleti, 2016, Drugs in Alzheimer’s disease dementia: an overview of current pharmacological management and future directions, Psychiatr Danub, 28, 136 Ihl, 2015, World Federation of societies of biological psychiatry guidelines for the pharmacological treatment of dementias in primary care, Int J Psychiatry Clin Pract, 19, 2, 10.3109/13651501.2014.961931 Selkoe, 1991, The molecular pathology of Alzheimer’s disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2 Piau, 2011, Progress in the development of new drugs in Alzheimer’s disease, J Nutr Health Aging, 15, 45, 10.1007/s12603-011-0012-x Ryseck, 2011, Cystatins: protease inhibitors, biomarkers, and immunomodulators, eBook Academic Collection (EBSCOhost), 1–39, 239 Abrahamson, 2003, Cystatins, Biochem Soc Symp, 70, 179, 10.1042/bss0700179 Kaur, 2012, Cystatin C in Alzheimer’s disease, Front Mol Neurosci, 5, 1 Merops the Peptidase Database. 2017. http://merops.sanger.ac.uk. (Accessed 17 October 2017). Levy, 2001, Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients, J Neuropathol Exp Neurol, 60, 94, 10.1093/jnen/60.1.94 Sastre, 2004, Binding of cystatin C to Alzheimer’s amyloid beta inhibits in vitro amyloid fibril formation, Neurobiol Aging, 25, 1033, 10.1016/j.neurobiolaging.2003.11.006 Selenica, 2007, Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils, Scand J Clin Lab Invest, 67, 179, 10.1080/00365510601009738 Mi, 2007, Cystatin C inhibits amyloid-beta deposition in Alzheimer’s disease mouse models, Nat Genet, 39, 1440, 10.1038/ng.2007.29 Tizon, 2010, Cystatin C protects neuronal cells from amyloid-beta-induced toxicity, J Alzheimers Dis, 19, 885, 10.3233/JAD-2010-1291 Gauthier, 2011, Protective mechanisms by cystatin C in neurodegenerative diseases, Front Biosci (Schol Ed), 1, 541 Anastasi, 1983, Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum, Biochem J, 211, 129, 10.1042/bj2110129 Mussap, 2004, Biochemistry and clinical role of human cystatin C, Crit Rev Clin Lab Sci, 41, 467, 10.1080/10408360490504934 Bode, 1988, The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases, EMBO J, 7, 2593, 10.1002/j.1460-2075.1988.tb03109.x Engh, 1993, Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy, J Mol Biol, 234, 1060, 10.1006/jmbi.1993.1659 Konopska, 2013, Influence of aminoglycoside antibiotics on chicken cystatin binding to renal brush-border membranes, J Pharm Pharmacol, 65, 988, 10.1111/jphp.12058 1986, 515 Stańczykiewicz, 2017, An animal model of the procognitive properties of cysteine protease inhibitor and immunomodulatory peptides based on colostrum, Adv Clin Exp Med, 26, 563, 10.17219/acem/62536 Stańczykiewicz, 2017, Potential protective effect of ovocystatin on aging-related cognitive impairment in rats, Post Hig Med Dośw, 71, 1202 Malicka-Blaszkiewicz, 2014, Ovocystatin affects actin cytoskeleton organization and induces proapoptotic activity, Acta Biochim Pol, 61, 753 Barrett, 1972, A new assay of cathepsin B1 and other thiol proteinases, Anal Biochem, 47, 280, 10.1016/0003-2697(72)90302-8 Tombaccini, 2001, A cystatin-based affinity procedure for the isolation and analysis of papain-like cysteine proteinases from tissue extracts, Anal Biochem, 289, 231, 10.1006/abio.2000.4937 Gołąb, 2012, Stabilization of monomeric chicken egg white cystatin, Przem Chem, 91, 741 Cegnar, 2004, Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity, Eur J Pharm Sci, 22, 357, 10.1016/j.ejps.2004.04.003 Wang, 2000, Lyophilization and development of solid protein pharmaceuticals, Int J Pharm, 203, 1, 10.1016/S0378-5173(00)00423-3 Jankowsky, 2001, Co-expression of multiple transgenes in mouse CNS: a comparison of strategies, Biomol Eng, 17, 157, 10.1016/S1389-0344(01)00067-3 Jankowsky, 2014, Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase, Hum Mol Genet, 13, 159, 10.1093/hmg/ddh019 Bromley-Brits, 2011, Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice, J Vis Exp, 53 Popik, 1999, A polypeptide isolated from early milk, facilitates learning and memory in rats, Pharmacol Biochem Behav, 64, 183, 10.1016/S0091-3057(99)00101-X Popik, 2001, Cognitive effects of Colostral-Val nonapeptide in aged rats, Behav Brain Res, 118, 201, 10.1016/S0166-4328(00)00323-5 Hook, 2008, Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein, J Biol Chem, 283, 7745, 10.1074/jbc.M708362200 Levy, 2008, Cystatin C: a potential target for Alzheimer’s treatment, Expert Rev Neurother, 8, 687, 10.1586/14737175.8.5.687 Steinhoff, 2001, Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques, Neurobiol Dis, 8, 647, 10.1006/nbdi.2001.0412 Kaeser, 2007, Cystatin C modulates cerebral beta-amyloidosis, Nat Genet, 39, 1437, 10.1038/ng.2007.23 Ghidoni, 2007, Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons, Neurobiol Aging, 28, 371, 10.1016/j.neurobiolaging.2006.01.007 Sun, 2008, Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer’s disease, Neuron, 60, 247, 10.1016/j.neuron.2008.10.001 Mathews, 2016, Cystatin C in aging and in Alzheimer’s disease, Ageing Res Rev, 32, 38, 10.1016/j.arr.2016.06.003 Taupin, 2000, FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor, Neuron, 28, 385, 10.1016/S0896-6273(00)00119-7 Hu, 2013, Role of cystatin C in amyloid precursor protein-induced proliferation of neural stem/progenitor cells, J Biol Chem, 288, 18853, 10.1074/jbc.M112.443671 Tizon, 2010, Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines, PLoS One, 5, e9819, 10.1371/journal.pone.0009819 Watanabe, 2014, Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity, Cell Death Dis, 5, e1497, 10.1038/cddis.2014.459 Sundelöf, 2008, Serum cystatin C and the risk of Alzheimer disease in elderly men, Neurology, 71, 1072, 10.1212/01.wnl.0000326894.40353.93 Ghidoni, 2010, Plasma cystatin C and risk of developing Alzheimer’s disease in subjects with mild cognitive impairment, J Alzheimers Dis, 22, 985, 10.3233/JAD-2010-101095 Nagai, 2005, Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B, Brain Res, 1066, 120, 10.1016/j.brainres.2005.10.063 Liu, 2014, Attenuation of early brain injury and learning deficits following experimental subarachnoid hemorrhage secondary to cystatin C: possible involvement of the autophagy pathway, Mol Neurobiol, 49, 1043, 10.1007/s12035-013-8579-3 Cloutier, 2006, Internalization and transcytosis of pancreatic enzymes by the intestinal mucosa, J Histochem Cytochem, 54, 781, 10.1369/jhc.5A6877.2006 Łukaszyk, 2001, Immunocytochemical observations on the organ distribution of exogenous monomeric and dimerized lysozyme, Folia Histochem Cytobiol, 39, 321 Vlassara, 2007, Glycotoxins in the diet promote diabetes and diabetic complications, Curr Diab Rep, 7, 235, 10.1007/s11892-007-0037-z Miner-Williams, 2014, Are intact peptides absorbed from the healthy gut in the adult human?, Nutr Res Rev, 27, 308, 10.1017/S0954422414000225 Nishiura, 1995, Translocation of orally administered rat salivary cystatin into serum and kidney, Arch Oral Biol, 40, 285, 10.1016/0003-9969(94)00177-D Freskgård, 2017, Antibody therapies in CNS diseases, Neuropharmacology, 120, 38, 10.1016/j.neuropharm.2016.03.014 Reiber, 2001, Dynamics of brain-derived proteins in cerebrospinal fluid, Clin Chim Acta, 310, 173, 10.1016/S0009-8981(01)00573-3 Zheng, 2015, Thinking outside the brain for cognitive improvement: is peripheral immunomodulation on the way?, Neuropharmacology, 96, 94, 10.1016/j.neuropharm.2014.06.020 Friedland, 2015, Mechanisms of molecular mimicry involving the microbiota in neurodegeneration, J Alzheimers Dis, 45, 349, 10.3233/JAD-142841 Zavasnik-Bergant, 2008, Cystatin protease inhibitors and immune functions, Front Biosci, 13, 4625, 10.2741/3028 Ochieng, 2010, Cystatin superfamily, J Health Care Poor Underserved, 21, 51, 10.1353/hpu.0.0257 Quan, 2009, Highly efficient and low-cost purification of lysozyme: a novel tris(hydroxymethyl)aminomethane immobilized affinity column, J Chromatogr B Analyt Technol Biomed Life Sci, 877, 594, 10.1016/j.jchromb.2009.01.018 Sosnowska, 2011, Bioactive substances of hen eggs: the biomedical importance and technological possibility for production in an industrial scale, Przem Chem, 90, 174